Overview
Xianglong Kong practices practicing medicine in Harbin, China.
Their clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Trophoblastic Tumor Placental Site, and Hairy Cell Leukemia (HCL).
They are actively involved in clinical research, co-authoring 35 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xianglong T. Kong
Is Xianglong T. Kong a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Xianglong T. Kong is classified as an Experienced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xianglong T. Kong participate in research or clinical trials?
Yes. Xianglong T. Kong has published 35 articles and abstracts on conditions like Lung Cancer. You can view a list of Xianglong T. Kong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hairy Cell Leukemia (HCL)Kong isExperienced. Learn about Hairy Cell Leukemia (HCL).
- Lung AdenocarcinomaKong isExperienced. Learn about Lung Adenocarcinoma.
- Lung CancerKong isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- RUNX1 Familial Platelet Disorder
- Trophoblastic Tumor Placental Site